Patents Assigned to Century Limited
  • Publication number: 20230399652
    Abstract: Four genes, A622, NBB1, PMT, and QPT, can be influenced for increasing nicotinic alkaloid levels in Nicotiana plants, as well as for synthesizing nicotinic alkaloids in non-nicotine producing plants and cells. In particular, overexpressing one or more of A622, NBB1, PMT, and QPT may be used to increase nicotine and nicotinic alkaloid levels in tobacco plants. Non-nicotine producing cells can be engineered to produce nicotine and related compounds by overexpressing A622 and NBB1.
    Type: Application
    Filed: June 5, 2023
    Publication date: December 14, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Takashi HASHIMOTO, Masataka KAJIKAWA
  • Patent number: 11839231
    Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: December 12, 2023
    Assignee: 22nd Century Limited, LLC
    Inventors: Takashi Hashimoto, Akira Kato
  • Publication number: 20230383303
    Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.
    Type: Application
    Filed: April 11, 2023
    Publication date: November 30, 2023
    Applicant: 22nd Century Limited, LLC
    Inventor: Paul Rushton
  • Publication number: 20230374531
    Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.
    Type: Application
    Filed: April 10, 2023
    Publication date: November 23, 2023
    Applicant: 22nd Century Limited, LLC
    Inventor: Paul Rushton
  • Publication number: 20230340510
    Abstract: MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in Nicotiana plants. In particular, suppressing or overexpressing one or more of MPO1 and MPO2 may be used to decrease or increase nicotine and nicotinic alkaloid levels in tobacco plants. Suppression or overexpression of one or more of MPO1 and MPO2 may be used in combination with modification of expression of other genes encoding enzymes on the nicotinic alkaloid biosynthetic pathway such as A622, NBB1, PMT, and QPT.
    Type: Application
    Filed: January 5, 2023
    Publication date: October 26, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Takashi Hashimoto, Akira Kato
  • Publication number: 20230340514
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: January 31, 2023
    Publication date: October 26, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 11667924
    Abstract: Four genes, A622, NBB1, PMT, and QPT, can be influenced for increasing nicotinic alkaloid levels in Nicotiana plants, as well as for synthesizing nicotinic alkaloids in non-nicotine producing plants and cells. In particular, overexpressing one or more of A622, NBB1, PMT, and QPT may be used to increase nicotine and nicotinic alkaloid levels in tobacco plants. Non-nicotine producing cells can be engineered to produce nicotine and related compounds by overexpressing A622 and NBB1.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: June 6, 2023
    Assignee: 22ND CENTURY LIMITED, LLC
    Inventors: Takashi Hashimoto, Masataka Kajikawa
  • Patent number: 11649463
    Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.
    Type: Grant
    Filed: August 6, 2020
    Date of Patent: May 16, 2023
    Assignee: 22nd Century Limited, LLC
    Inventor: Paul Rushton
  • Patent number: 11597941
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that positively regulates alkaloid biosynthesis, such as nicotine biosynthesis. In particular, the present disclosure provides methods for the inhibition of Nicotiana benthamiana auxin response factor 1 (NbTF1) to reduce alkaloid biosynthesis in plants.
    Type: Grant
    Filed: February 26, 2021
    Date of Patent: March 7, 2023
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan Page, Andrea T. Todd
  • Publication number: 20230048978
    Abstract: Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.
    Type: Application
    Filed: May 5, 2022
    Publication date: February 16, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan PAGE, Andrea T. TODD
  • Patent number: 11572568
    Abstract: MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in Nicotiana plants. In particular, suppressing or overexpressing one or more of MPO1 and MPO2 may be used to decrease or increase nicotine and nicotinic alkaloid levels in tobacco plants. Suppression or overexpression of one or more of MPO1 and MPO2 may be used in combination with modification of expression of other genes encoding enzymes on the nicotinic alkaloid biosynthetic pathway such as A622, NBB1, PMT, and QPT.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: February 7, 2023
    Assignee: 22nd Century Limited, LLC
    Inventors: Takashi Hashimoto, Akira Kato
  • Publication number: 20230029030
    Abstract: The gene encoding N-methylputrescine oxidase (MPO) and constructs comprising such DNA are provided, including methods of regulating MPO expression independently or with other alkaloid biosynthesis genes to modulate alkaloid production in plants and host cells. MPO genes or fragments thereof are useful for reducing pyrrolidine or tropane alkaloid production in plants, for increasing pyrrolidine or tropane alkaloid production in plants, and for producing an MPO enzyme in host cells.
    Type: Application
    Filed: June 22, 2022
    Publication date: January 26, 2023
    Applicant: 22nd Century Limited, LLC
    Inventors: Jonathan E. PAGE, Enwu Liu
  • Publication number: 20220325294
    Abstract: The present technology provides terpene synthase (TPS) promoters and TPS promoter consensus sequences from Cannabis, nucleotide sequences of the TPS promoters and consensus sequences, and uses of the promoters and consensus sequences for modulating the production of terpenes and other compounds in organisms The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the TPS promoters and consensus sequences. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the TPS promoters and consensus sequences.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 13, 2022
    Applicant: 22nd Century Limited, LLC
    Inventors: Paul Rushton, Sujon Sarowar
  • Publication number: 20220275387
    Abstract: The present technology provides transcription factors for modifying plant metabolism and nucleic acid molecules that encode such transcription factors. Also provide are methods of using these nucleic acids to modulate alkaloid production in plants and for producing plant and plant cells having altered alkaloid content. Disclosed herein are methods and compositions for modulating nicotine biosynthesis in plants.
    Type: Application
    Filed: August 4, 2020
    Publication date: September 1, 2022
    Applicants: University of Virginia Patent Foundation, 22nd Century Limited, LLC
    Inventors: Michael P. TIMKO, Hai Liu
  • Patent number: 11396656
    Abstract: The gene encoding N-methylputrescine oxidase (MPO) and constructs comprising such DNA are provided, including methods of regulating MPO expression independently or with other alkaloid biosynthesis genes to modulate alkaloid production in plants and host cells. MPO genes or fragments thereof are useful for reducing pyrrolidine or tropane alkaloid production in plants, for increasing pyrrolidine or tropane alkaloid production in plants, and for producing an MPO enzyme in host cells.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: July 26, 2022
    Assignee: 22nd Century Limited, LLC
    Inventors: Jonathan E. Page, Enwu Liu
  • Publication number: 20220087306
    Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.
    Type: Application
    Filed: August 31, 2021
    Publication date: March 24, 2022
    Applicant: 22nd Century Limited, LLC
    Inventors: Takashi HASHIMOTO, Akira KATO
  • Publication number: 20210371870
    Abstract: The present technology provides dominant negative forms of transcription factors for modifying nicotine biosynthesis and nucleic acid molecules that encode such dominant negative transcription factors. Also provided are methods of using these nucleic acids to modulate nicotine production in plants and for producing plants and plant cells having reduced nicotine content.
    Type: Application
    Filed: December 23, 2020
    Publication date: December 2, 2021
    Applicant: 22nd Century Limited, LLC
    Inventor: Paul Rushton
  • Publication number: 20210371869
    Abstract: The present technology provides transcription factors for modifying plant metabolism and nucleic acid molecules that encode such transcription factors. Also provided are methods of using these nucleic acids to modulate alkaloid production in plants and for producing plants and cells having altered alkaloid content.
    Type: Application
    Filed: December 30, 2020
    Publication date: December 2, 2021
    Applicant: 22nd Century Limited, LLC
    Inventor: Paul Rushton
  • Publication number: 20210317465
    Abstract: Four genes, A622, NBB1, PMT, and QPT, can be influenced for increasing nicotinic alkaloid levels in Nicotiana plants, as well as for synthesizing nicotinic alkaloids in non-nicotine producing plants and cells. In particular, overexpressing one or more of A622, NBB1, PMT, and QPT may be used to increase nicotine and nicotinic alkaloid levels in tobacco plants. Non-nicotine producing cells can be engineered to produce nicotine and related compounds by overexpressing A622 and NBB1.
    Type: Application
    Filed: January 4, 2021
    Publication date: October 14, 2021
    Applicant: 22nd Century Limited, LLC
    Inventors: Takashi HASHIMOTO, Masataka KAJIKAWA
  • Patent number: 11109617
    Abstract: Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: September 7, 2021
    Assignee: 22nd Century Limited, LLC
    Inventors: Takashi Hashimoto, Akira Kato